By Professor Tracey O'Brien

Journal articles

Rapport F; Smith J; O'Brien TA; Tyrrell VJ; Mould EVA; Long JC; Gul H; Braithwaite J, 2020, 'Development of an implementation and evaluation strategy for the Australian 'Zero Childhood Cancer' (Zero) Program: a study protocol', BMJ Open, 10, http://dx.doi.org/10.1136/bmjopen-2019-034522

Hamad N; Gottlieb D; Ritchie D; Kennedy G; Watson AM; Greenwood M; Doocey R; Perera T; Spencer A; Wong E; O'Brien T; Shaw P; Conyers R; Cole T; Milliken S; Bardy P; Larsen S; Lai H; Butler A; Fraser C; Bajel A; Butler J; Kerridge I; Purtill D, 2020, 'Bone Marrow Transplant Society of Australia and New Zealand COVID-19 consensus position statement', Internal Medicine Journal, 50, pp. 774 - 775, http://dx.doi.org/10.1111/imj.14867

Grant A; Chapman LRM; Mitchell R; O’Brien TA, 2020, 'Engraftment syndrome following hematopoietic stem cell transplant: A review of the literature', Clinical Transplantation, 34, http://dx.doi.org/10.1111/ctr.13875

Smith J; Rapport F; O'Brien TA; Smith S; Tyrrell VJ; Mould EVA; Long JC; Gul H; Cullis J; Braithwaite J, 2020, 'The rise of rapid implementation: A worked example of solving an existing problem with a new method by combining concept analysis with a systematic integrative review', BMC Health Services Research, 20, http://dx.doi.org/10.1186/s12913-020-05289-0

Keating AK; Langenhorst J; Wagner JE; Page KM; Veys P; Wynn RF; Stefanski H; Elfeky R; Giller R; Mitchell R; Milano F; O'Brien TA; Dahlberg A; Delaney C; Kurtzberg J; Verneris MR; Boelens JJ, 2020, 'The influence of stem cell source on transplant outcomes for pediatric patients with acute myeloid leukemia (vol 3, pg 1118, 2019)', BLOOD ADVANCES, 4, pp. 1081 - 1081, http://dx.doi.org/10.1182/bloodadvances.2020001753

Chapman LRM; Smith B; McCleary K; Mitchell R; O'Brien TA, 2020, 'Creating a CAR-T Cell Presentation Tool for the Emergency Room', BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 26, pp. S381 - S382, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000516887900600&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Manoharan N; O'Brien T, 2020, 'Childhood cancer: unique opportunities and inherent challenges', Medical Journal of Australia, 212, pp. 110 - 111, http://dx.doi.org/10.5694/mja2.50487

McGill BC; Wakefield CE; Hetherington K; Munro LJ; Warby M; Lau L; Tyrrell V; Ziegler DS; O’brien TA; Marshall GM; Malkin D; Hansford JR; Tucker KM; Vetsch J; O'Brien T, 2020, '“Balancing Expectations with Actual Realities”: Conversations with Clinicians and Scientists in the First Year of a High-Risk Childhood Cancer Precision Medicine Trial', Journal of Personalized Medicine, 10, pp. 9, http://dx.doi.org/10.3390/jpm10010009

Chapman LR; Molloy L; Wright F; Oswald C; Adnum K; O'Brien TA; Mitchell R, 2020, 'Implementation of situational awareness in the pediatric oncology setting. Does a ‘huddle’ work and is it sustainable?', Journal of Pediatric Nursing, 50, pp. 75 - 80, http://dx.doi.org/10.1016/j.pedn.2019.10.016

Gray PE; McCarthy H; Siggs OM; Saleem MA; O' Brien T; Frith K; Ziegler JB; Kitching AR; Fogo AB; Hudson BG; Pedchenko V, 2019, 'Molecular Analysis of Goodpasture’s Disease Following Hematopoietic Stem Cell Transplant in a Pediatric Patient, Recalls the Conformeropathy of Wild-Type Anti-GBM Disease', Frontiers in Immunology, 10, http://dx.doi.org/10.3389/fimmu.2019.02659

Selim A; Alvaro F; Cole CH; Fraser CJ; Mechinaud F; O'Brien TA; Shaw PJ; Tapp H; Teague L; Nivison-Smith I; Moore AS, 2019, 'Hematopoietic stem cell transplantation for children with acute myeloid leukemia in second remission: A report from the Australasian Bone Marrow Transplant Recipient Registry and the Australian and New Zealand Children's Haematology Oncology Group', Pediatric Blood and Cancer, 66, http://dx.doi.org/10.1002/pbc.27812

Robertson EG; Wakefield CE; Cohn RJ; Battisti RA; Donoghoe MW; Ziegler DS; Fardell JE; Mitchell R; O'Brien TA, 2019, 'Piloting a parent and patient decision aid to support clinical trial decision making in childhood cancer', Psycho-Oncology, 28, pp. 1520 - 1529, http://dx.doi.org/10.1002/pon.5109

Vetsch J; Wakefield CE; Techakesari P; Warby M; Ziegler DS; O'Brien TA; Drinkwater C; Neeman N; Tucker K, 2019, 'Healthcare professionals’ attitudes toward cancer precision medicine: A systematic review', Seminars in Oncology, 46, pp. 291 - 303, http://dx.doi.org/10.1053/j.seminoncol.2019.05.001

Shen S; Ferrell K; Chaudhry K; Vu A; Nordon R; O'Brien T, 2019, 'MODULATION OF ANTI-TUMOUR ACTIVITY OF EX VIVO EXPANDED NK AND GD2CAR-NK CELLS AGAINST NEUROBLASTOMA', CYTOTHERAPY, 21, pp. S20 - S20, http://dx.doi.org/10.1016/j.jcyt.2019.03.317

Keating AK; Langenhorst J; Wagner JE; Page KM; Veys P; Wynn RF; Stefanski H; Elfeky R; Giller R; Mitchell R; Milano F; O’Brien TA; Dahlberg A; Delaney C; Kurtzberg J; Verneris MR; Boelens JJ, 2019, 'The influence of stem cell source on transplant outcomes for pediatric patients with acute myeloid leukemia', Blood Advances, 3, pp. 1118 - 1128, http://dx.doi.org/10.1182/bloodadvances.2018025908

Al Yazidi LS; Mitchell R; Palasanthiran P; O’Brien TA; McMullan B, 2019, 'Management and prevention of cytomegalovirus infection in paediatric hematopoietic stem cell transplant (HSCT) recipients: A binational survey', Pediatric Transplantation, 23, http://dx.doi.org/10.1111/petr.13458

Mitchell R; Cole T; Shaw PJ; Mechinaud F; O'Brien T; Fraser C, 2019, 'TCR α⁺β⁺/CD19⁺ cell–depleted hematopoietic stem cell transplantation for pediatric patients', Pediatric Transplantation, 23, http://dx.doi.org/10.1111/petr.13517

Fioredda F; Iacobelli S; Korthof ET; Knol C; van Biezen A; Bresters D; Veys P; Yoshimi A; Fagioli F; Mats B; Zecca M; Faraci M; Miano M; Arcuri L; Maschan M; O'Brien T; Diaz MA; Sevilla J; Smith O; Peffault de Latour R; de la Fuente J; Or R; Van Lint MT; Tolar J; Aljurf M; Fisher A; Skorobogatova EV; Diaz de Heredia C; Risitano A; Dalle JH; Sedláček P; Ghavamzadeh A; Dufour C, 2018, 'Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita', British Journal of Haematology, 183, pp. 110 - 118, http://dx.doi.org/10.1111/bjh.15495

Turcotte LM; Wang T; Hemmer MT; Spellman SR; Arora M; Couriel D; Alousi A; Pidala J; Abdel-Azim H; Ahmed I; Beitinjaneh A; Buchbinder D; Byrne M; Callander N; Chao N; Choi SW; Defilipp Z; Gadalla SM; Gale RP; Gergis U; Hashmi S; Hematti P; Holmberg L; Inamoto Y; Kamble RT; Lehmann L; MacMillan MA; McIver Z; Nishihori T; Norkin M; O'Brien T; Olsson RF; Reshef R; Saad A; Savani BN; Schouten HC; Seo S; Solh M; Verdonck L; Vij R; Wirk B; Yared J; Horowitz MM; Knight JM; Verneris MR, 2018, 'Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation', Bone Marrow Transplantation, 53, pp. 932 - 937, http://dx.doi.org/10.1038/s41409-018-0100-1

Harris AC; Boelens JJ; Ahn KW; Fei M; Abraham A; Artz A; Dvorak C; Frangoul H; Freytes C; Gale RP; Hong S; Lazarus HM; Loren A; Mineishi S; Nishihori T; O’Brien T; Williams K; Pasquini MC; Levine JE, 2018, 'Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine', Blood Advances, 2, pp. 1198 - 1206, http://dx.doi.org/10.1182/bloodadvances.2018016956

Dolnikov A; David C. Bishop, Ning Xu, Benjamin Tse, Tracey A. O’Brien, David J. Gottlieb, Alla , 2018, 'PiggyBac-engineered T-cells expressing CD19-specific CARs that lack IgG1 Fc spacers have potent activity against B-ALL xenografts.', Molecular Therapy, http://dx.doi.org/10.1016/j.ymthe.2018.05.007

Robertson EG; Wakefield CE; Cohn RJ; O'Brien T; Ziegler DS; Fardell JE, 2018, 'The development of delta: Using agile to develop a decision aid for pediatric oncology clinical trial enrollment', JMIR Research Protocols, 7, pp. e119, http://dx.doi.org/10.2196/resprot.9258

Van Den Broek BA; Page K; Paviglianiti A; Hol J; Allewelt H; Volt F; Michel G; Diaz MA; Bordon V; O'Brien T; Shaw PJ; Kenzey C; Al-Seraihy A; Van Hasselt PM; Gennery AR; Gluckman E; Rocha V; Ruggeri A; Kurtzberg J; Boelens JJ, 2018, 'Early and late outcomes after cord blood transplantation for pediatric patients with inherited leukodystrophies', Blood Advances, 2, pp. 49 - 60, http://dx.doi.org/10.1182/bloodadvances.2017010645

Dolnikov A; Xu N; Tse B; Shen S; O'Brien T, 2018, 'Bromodomain inhibitor jq1 modulates immune suppressive pathways in neuroblastoma and enhances CARGD2T cell therapy', Cytotherapy, 20, pp. S97 - S97, http://dx.doi.org/10.1016/j.jcyt.2018.02.285

Dolnikov A; Xu N; Tse B; O'Brien T, 2018, 'Epigenetic agent modulates tumour microenvironment and potentiates cart cell therapy', Cytotherapy, 20, pp. S97 - S97, http://dx.doi.org/10.1016/j.jcyt.2018.02.284

Chapman LRM; Falato K; Oswald C; Mitchell R; O'Brien TA, 2018, 'How Clean are We? Impact of Education on Cleaning Outcomes in the Pediatric BMT Setting', Biology of Blood and Marrow Transplantation, 24, pp. S448 - S449, http://dx.doi.org/10.1016/j.bbmt.2017.12.723

Mitchell R; Cole T; Shaw PJ; Mechinaud F; O'Brien TA; Fraser C, 2018, 'TCR Α+ Β+/CD19+ Cell Depleted Haematopoietic Stem Cell Transplantation for Paediatric Patients', Biology of Blood and Marrow Transplantation, 24, pp. S435 - S435, http://dx.doi.org/10.1016/j.bbmt.2017.12.522

Keating AK; Langenhorst J; Wagner JE; Page K; Veys P; Wynn RF; Stefanski H; Elfeky R; Giller R; Mitchell R; Milano F; O'Brien TA; Dahlberg A; Delaney C; Kurtzberg J; Verneris MR; Boelens J-J, 2018, 'The Influence of Stem Cell Source on Chronic-GvHD Free, Leukemia Free Transplant Survival in Pediatric Patients with Acute Myeloid Leukemia', Biology of Blood and Marrow Transplantation, 24, pp. S113 - S114, http://dx.doi.org/10.1016/j.bbmt.2017.12.029

Averbuch D; Tridello G; Hoek J; Mikulska M; Akan H; Yaňez San Segundo L; Pabst T; Özçelik T; Klyasova G; Donnini I; Wu D; Gülbas Z; Zuckerman T; Botelho De Sousa A; Beguin Y; Xhaard A; Bachy E; Ljungman P; De La Camara R; Rascon J; Ruiz Camps I; Vitek A; Patriarca F; Cudillo L; Vrhovac R; Shaw PJ; Wolfs T; O'Brien T; Avni B; Silling G; Al Sabty F; Graphakos S; Sankelo M; Sengeloev H; Pillai S; Matthes S; Melanthiou F; Iacobelli S; Styczynski J; Engelhard D; Cesaro S, 2017, 'Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group', Clinical Infectious Diseases, 65, pp. 1819 - 1828, http://dx.doi.org/10.1093/cid/cix646

Norman M; David C; Wainstein B; Ziegler JB; Cohn R; Mitchell R; O'Brien T; Russell S; Trahair T; Trickett A; Frith K; Gray P, 2017, 'Haematopoietic stem cell transplantation for primary immunodeficiency syndromes: A 5-year single-centre experience', Journal of Paediatrics and Child Health, 53, pp. 988 - 994, http://dx.doi.org/10.1111/jpc.13643

Page KM; Labopin M; Ruggeri A; Michel G; Diaz de Heredia C; O'Brien T; Picardi A; Ayas M; Bittencourt H; Vora AJ; Troy J; Bonfim C; Volt F; Gluckman E; Bader P; Kurtzberg J; Rocha V, 2017, 'Factors Associated with Long-Term Risk of Relapse after Unrelated Cord Blood Transplantation in Children with Acute Lymphoblastic Leukemia in Remission', Biology of Blood and Marrow Transplantation, 23, pp. 1350 - 1358, http://dx.doi.org/10.1016/j.bbmt.2017.04.015

Vrooman LM; Millard HR; Brazauskas R; Majhail NS; Battiwalla M; Flowers ME; Savani BN; Akpek G; Aljurf M; Bajwa R; Baker KS; Beitinjaneh A; Bitan M; Buchbinder D; Chow E; Dandoy C; Dietz AC; Diller L; Gale RP; Hashmi SK; Hayashi RJ; Hematti P; Kamble RT; Kasow KA; Kletzel M; Lazarus HM; Malone AK; Marks DI; O'Brien TA; Olsson RF; Ringden O; Seo S; Steinberg A; Yu LC; Warwick A; Shaw B; Duncan C, 2017, 'Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age', Biology of Blood and Marrow Transplantation, 23, pp. 1327 - 1334, http://dx.doi.org/10.1016/j.bbmt.2017.04.017

Shen S; O'Brien T, 2017, 'MODULATION OF ANTI-TUMOUR ACTIVITY OF EX VIVO EXPANDED NK CELLS AGAINST NEUROBLASTOMA VIA HDACI AND PD1/PD-Ll BLOCKADE', CYTOTHERAPY, 19, pp. S13 - S14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000399265400019&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Shadur B; Trahair TN; O'Brien T; Russell SJ; Ziegler JB, 2017, 'Desensitisation to liposomal amphotericin B', JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 5, pp. 181 - 183, http://dx.doi.org/10.1016/j.jaip.2016.08.006

Nelson AS; Vajdic CM; Ashton LJ; Le Marsney RE; Nivison-Smith I; Wilcox L; Dodds AJ; O'Brien TA, 2017, 'Incident cancers and late mortality in Australian children treated by allogeneic stem cell transplantation for non-malignant diseases', Pediatric Blood and Cancer, 64, pp. 197 - 202, http://dx.doi.org/10.1002/pbc.26219

Ruggeri A; Volt F; Locatelli F; Michel G; Diaz de Heredia C; Abecasis M; Zecca M; Vora A; Yakouben K; O'Brien TA; Giardino S; Cornish J; Rocha V; Peters C; Bader P; Gluckman E; Dalle JH, 2017, 'Unrelated Cord Blood Transplantation for Acute Leukemia Diagnosed in the First Year of Life: Outcomes and Risk Factor Analysis', Biology of Blood and Marrow Transplantation, 23, pp. 96 - 102, http://dx.doi.org/10.1016/j.bbmt.2016.10.014

Shekhovtsova Z; Bonfim C; Ruggeri A; Nichele S; Page K; AlSeraihy A; Barriga F; de Toledo Codina JS; Veys P; Boelens JJ; Mellgren K; Bittencourt H; O'Brien T; Shaw PJ; Chybicka A; Volt F; Giannotti F; Gluckman E; Kurtzberg J; Gennery AR; Rocha V; Eurocord CBCOCTAIWPOTEBMTFUOPDUMCAIEWPOTEBMT, 2017, 'A risk factor analysis of outcomes after unrelated cord blood transplantation for children with Wiskott-Aldrich syndrome.', Haematologica, 102, pp. 1112 - 1119, http://dx.doi.org/10.3324/haematol.2016.158808

Harris AC; Boelens JJ; Ahn KW; Fei M; Abraham A; Artz A; Dvorak CC; Frangoul H; Freytes CO; Gale RP; Hong S; Lazarus HM; Mineishi S; Nishihori T; O'Brien T; Williams KM; Pasquini MC; Levine JE, 2016, 'Comparison of Outcomes for Myeloablative Conditioning Regimens Combining Busulfan with Either Cyclophosphamide or Fludarabine in Children', BLOOD, 128, http://dx.doi.org/10.1182/blood.V128.22.664.664

Bresters D; Lawitschka A; Cugno C; Pötschger U; Dalissier A; Michel G; Vettenranta K; Sundin M; Al-Seraihy A; Faraci M; Sedlacek P; Versluys AB; Jenkins A; Lutz P; Gibson B; Leiper A; Diaz MA; Shaw PJ; Skinner R; O'Brien TA; Salooja N; Bader P; Peters C, 2016, 'Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters', Bone Marrow Transplantation, 51, pp. 1482 - 1489, http://dx.doi.org/10.1038/bmt.2016.139

Westbrook JI; Li L; Raban MZ; Baysari MT; Mumford V; Prgomet M; Georgiou A; Kim T; Lake R; McCullagh C; Dalla-Pozza L; Karnon J; O'Brien TA; Ambler G; Day R; Cowell CT; Gazarian M; Worthington R; Lehmann CU; White L; Barbaric D; Gardo A; Kelly M; Kennedy P, 2016, 'Stepped-wedge cluster randomised controlled trial to assess the effectiveness of an electronic medication management system to reduce medication errors, adverse drug events and average length of stay at two paediatric hospitals: A study protocol', BMJ Open, 6, pp. e011811, http://dx.doi.org/10.1136/bmjopen-2016-011811

Koenecke C; Heim D; van Biezen A; Heuser M; Aljurf M; Kyrcz-Krzemien S; Volin L; de Souza CA; Gedde-Dahl T; Sengeloev H; Schanz U; Komarnicki M; Arroyo CH; Tholouli E; Gluckman E; Esquirol A; Yakoub-Agha I; Gurman G; Olavarria E; Kroeger N; Rovira M; Kahls P; Alegre A; Nemet D; Stamatovic D; Vitek A; Hamladji R; Hellmann A; Chybicka A; Wiktor-Jedrzejczak W; Maiolino A; Borne PVD; Chevallier P; Littlewood T; Crawley C; Mistrik M; Schaefer-Eckart K; Orchard K; Maertens J; van Lint M; Ethell M; Vettenranta K; Broom A; Deconinck E; Schaap N; Petersen E; Espiga CR; Di Bartolomeo P; Brown P; Beelen D; Leblond V; Leleu X; Carlson K; Milpied N; Collin M; Johansson J; Cairoli R; Serwe H; Schleuning M; Ozturk M; Lisukov IA; Robinson S; Uckan-Cetinkaya D; Rohrlich P; Visani G; Merli F; Sanz M; Michallet M; Halaburda K; O'Brien T; Jindra P; Feldman L; Theobald M; Favre C; Rodeghiero F; Finke J, 2016, 'Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party', BONE MARROW TRANSPLANTATION, 51, pp. 1259 - 1261, http://dx.doi.org/10.1038/bmt.2016.97

Green D; O'Brien T, 2016, 'Restoration to normal physiology without the use of excessive fluids', BRITISH JOURNAL OF ANAESTHESIA, 117, pp. 264 - 266, http://dx.doi.org/10.1093/bja/aew203

Nelson AS; Marsh RA; Myers KC; Davies SM; Jodele S; O'Brien TA; Mehta PA, 2016, 'A Reduced-Intensity Conditioning Regimen for Patients with Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation', Biology of Blood and Marrow Transplantation, 22, pp. 884 - 888, http://dx.doi.org/10.1016/j.bbmt.2016.01.026

Vajdic CM; Mayson E; Dodds AJ; O'Brien T; Wilcox L; Nivison-Smith I; Le Marsney R; Daniels B; Ashton LJ; Tan J; Bilmon I; Aarons D; Tran S; Gibson J; Johnston A; Greenwood M; Forbes M; Hertzberg M; Huang G; Spencer A; Muirhead J; Szer J; Mason K; Lewis I; To C; Durrant S; Western R; Cannell P; Buffery S; Oswald C; Nelson A; Shaw P; Pearson L; Tiedemann K; Scoyne M; Fraser C; Seljak J; Cole C; Rowland K; Gough H; Tapp H; Green N; Moa A; McRae J; Jenkins M; Hicks J; Chaplin K, 2016, 'Second Cancer Risk and Late Mortality in Adult Australians Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Population-Based Cohort Study', Biology of Blood and Marrow Transplantation, 22, pp. 949 - 956, http://dx.doi.org/10.1016/j.bbmt.2016.01.027

Michel G; Cunha R; Ruggeri A; O'Brien TA; Bittencourt H; Dalle JH; Locatelli F; Iori AP; Mauad M; Oudin C; Giannotti F; Volt F; Gluckman E; Bader P; Rocha V, 2016, 'Unrelated cord blood transplantation for childhood acute myelogenous leukemia: The influence of cytogenetic risk group stratification', Leukemia, 30, pp. 1180 - 1183, http://dx.doi.org/10.1038/leu.2015.243

Chapman L; Johnston K; Maurice L; O'Brien T, 2016, 'Developing a Hematopoietic Progenitor Cell Transplant (HPCT) Timeline for Educating Nursing Staff and Families', BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 22, pp. S463 - S463, http://dx.doi.org/10.1016/j.bbmt.2015.11.1060

Koyyalamudi SR; Kuzhiumparambil U; Nath CE; Byrne JA; Fraser CJ; O'brien TA; Earl JW; Shaw PJ, 2016, 'Development and validation of a high pressure liquid Chromatography-UV method for the determination of treosulfan and its epoxy metabolites in human plasma and its application in pharmacokinetic studies', Journal of Chromatographic Science, 54, pp. 326 - 333, http://dx.doi.org/10.1093/chromsci/bmv145

Vrooman L; Millard H; Brazauskas R; Majhail NS; Battiwallas M; Flowers MED; Savani BN; Akpek G; Aljurf MD; Bajwa R; Baker KS; Beitinjaneh A; Bitan M; Buchbinder D; Dandoy CE; Gale RP; Hayashi RJ; Hematti P; Kamble RT; Kasow KA; Kletzel M; Lazarus HM; Malone AK; O'Brien T; Olsson R; Reddy V; Willert JR; Ringden O; Schears RM; Seo S; Steinberg A; Yu LC; Shaw BE; Duncan C, 2016, 'Survival and Late Effects of Children Undergoing Myeloablative Allogeneic HCT at Less Than Three Years of Age: A Report from the Center for International Blood and Marrow Transplant Research', BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 22, pp. S28 - S29, http://dx.doi.org/10.1016/j.bbmt.2015.11.311

Dolnikov A; Yang S; Shen S; Xu N; Chaudhry K; Nordon R; O'Brien T, 2016, 'Prolonging CART Cell Persistence Using Conditioning with 5-Azacytidine', Cytotherapy, 18, pp. S98 - S98, http://dx.doi.org/10.1016/j.jcyt.2016.03.201

Shen S; Xu N; Yang S; O'Brien T; Dolnikov A, 2016, 'Stem Cell Approach to Generate Chimeric Antigen Receptor Modified Immune Effector Cells to Treat Cancer', Cytotherapy, 18, pp. S101 - S101, http://dx.doi.org/10.1016/j.jcyt.2016.03.211

Back to profile page